News about Global Pharma

Lupin, Sino Universal Pharmaceuticals Ink License and Supply Agreement for Tiotropium DPI in China

Lupin has signed a license and supply agreement with Sino Universal Pharmaceuticals to commercialise its Tiotropium Dry Powder Inhaler for COPD treatment in China, marking a strategic expansion of its respiratory portfolio in the Chinese market.

Global Pharma | 16/06/2025 | By Manvi |  141

DGTR identifies key stakeholders in anti-dumping probe on EDA imports from China, EU, Saudi Arabia & Taiwan

EDA is an organic compound used as a building block in the synthesis of various chemicals, including those used in pharmaceuticals. It is also used as an excipient to help formulate and administer a drug, such as in creams and ointments.

Global Pharma | 16/06/2025 | By Darshana |  198

Safe Group Secures FDA 510(k) Clearance for SpineUp's Frida Solution

Safe Group has announced that SpineUp’s innovative cervical plate, Frida, has received FDA 510(k) clearance, marking a key milestone in its expansion into the North American market.

Global Pharma | 13/06/2025 | By Manvi |  166

MolecuLight i:X Proven Effective in Treating Deep Wound Infections: Taiwan Study

MolecuLight Inc. and its Taiwanese distributor, Healtdeva Company Ltd. , congratulate researchers at Taipei Shuang-Ho Hospital in Taiwan on the publication of groundbreaking findings with MolecuLight.

Global Pharma | 13/06/2025 | By Manvi |  146

World Precision Instruments Launches Next-Generation Multiplexed TEER-on-a-Chip Platform

The co-developed platform integrates WPI's gold-standard EVOM™ measurement technology with SynVivo's SynTEER™ multiplexed OOC models with embedded electrodes, providing researchers with a seamless solution for performing TEER measurements directly within microfluidic chips.

Global Pharma | 12/06/2025 | By Manvi |  266

Moon Surgical Showcases Maestro System at NVIDIA GTC Paris During VivaTech 2025

Moon Surgical announced its participation at NVIDIA GTC Paris during VivaTech2025. In collaboration with NVIDIA, Moon Surgical is highlighting the Maestro System as a pioneering example of Physical AI in action—empowering surgical teams across the globe.

Global Pharma | 12/06/2025 | By Manvi |  111

Broad Institute and Bayer Extend Cardiovascular Research Collaboration by 5 years

The Broad Institute and Bayer have extended their decade-long cardiovascular research collaboration by another five years to accelerate precision cardiology through human genomics and novel therapeutic development.

Global Pharma | 12/06/2025 | By Manvi

Azurity Pharmaceuticals Secures FDA Approval of XIFYRM (meloxicam injection) for Moderate-to-Severe Pain management in Adults

Azurity Pharmaceuticals has received US FDA approval for XIFYRM, a once-daily IV meloxicam injection for moderate-to-severe pain management in adults, offering a non-opioid alternative for multimodal analgesia.

Global Pharma | 12/06/2025 | By Manvi |  195

Axsome Launches SYMBRAVO in US for Acute Migraine Treatment in Adults

Axsome Therapeutics has announced the US prescription availability of SYMBRAVO (meloxicam and rizatriptan), a novel dual-action treatment for acute migraine with or without aura in adults.

Global Pharma | 11/06/2025 | By Manvi |  289

WuXi Biologics and Virogen Biotechnology Enter Commercial Manufacturing Partnership

WuXi Biologics has announced a strategic partnership with Virogen Biotechnology Inc. to support the commercial manufacturing of VG712, a novel immunotherapy targeting T cell dysregulation.

Global Pharma | 11/06/2025 | By Manvi |  232